Dr. Michael Crow, Arizona State University President, shares insights on education, atheletics and leadership with Charile Rose on CBS News. Continue reading
Category Archives: Blogs
AZBio Blogs
Watson Update 2012
In October 2011, David Kerr of IBM introduced us to IBM’s Watson and the future of healthcare at the 2011 AZBio Awards. On June 26th, IBM’s Dr. Martin Kohn provided the latest news. Here is what he had to share:Continue reading
“Best Hospitals” add the Total Artificial Heart in their Tool Box
50% of U.S. News & World Report’s “Best Hospitals” for Cardiology & Heart Surgery Making the Total Artificial Heart Part of Their Toolbox Continue reading
Genome-wide association studies focus on evolutionary information
Evolutionary information improves discovery of mutations associated with diseasesContinue reading
Washington Run Down – July 2012
As a member of the CSBA (Council of State Bioscience Associations), AZBio receives a monthy run down of the latest news from our nation’s capitol.
Here is the latest Washington Update from BIO and the C2Group. Continue reading
Biochemist awarded ASU’s coveted Galvin Professorship
An expert in the structural biochemistry and biophysics of membrane proteins, ASU’s Galvin Professor Petra Fromme’s research efforts and multi-institution team are revolutionizing core understanding about infectious disease and creating exciting developments in medicine and clean energy. Continue reading
Flagship Sails Into New Waters With Expansion Into Neuroscience Pathology Services
Flagship Biosciencs expands quantitative histopathology services into neurodegenerative disease and neurotoxicity
Stereological and classical image analysis approaches help to more accurately quantify neuropathology and model treatment efficacyContinue reading
MDUFA, PDUFA, FDASIA head out to Pennsylvania Avenue
After a long and collaborative effort between the FDA and Industry, the Food and Drug Administration Safety and Innovation Act (FDASIA) including reauthorization of MDUFA and PDUFA head to the White House for signature into law. Continue reading
June 2012 Washington Run Down
A Washington Update for AZBio Members.Continue reading
The Medical Device Tax: Repeal it for the sake of innovators and patients
As industry leaders we all need to stay in the loop on key issues that affect our industry and our state. One of those issues is the 2.3% Medical Device Tax. When we were out in DC last April, AZBio leadership met with all of our Congressional teams to share information on how this tax impacts our industry and our state . In addition to sharing with them what is happening here in Arizona, we asked them if they would keep us “in the loop” on what is happening at our nation’s capitol.
On Thursday, June 7, 2012 we got some important news from Capitol Hill.
Read on for a special “In the Loop” guest post by Congressman Paul Gosar, R-AZContinue reading